Key result
Sickle cell readmissions linked to higher comorbidities, more complications, greater prior utilization, and longer stays.
Why the study?
What patient and hospitalization factors are associated with 30-day readmissions in adults with sickle cell disease?
Case-Control
No
What patient and hospitalization factors are associated with 30-day readmissions in adults with sickle cell disease?
In patients with sickle cell disease, 30-day readmissions are associated with greater disease severity, higher comorbidity, and longer initial hospital length of stay.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in sickle cell disease; leaves open whether targeting these factors reduces readmissions.
OBJECTIVES: Sickle cell disease (SCD) is associated with a high level of emergency department and hospital utilization, as well as a high rate of hospital readmissions. At Johns Hopkins Hospital, as at other institutions, SCD accounts for a large proportion of readmissions. Our study examined patient and hospitalization factors involved in readmissions at Johns Hopkins Hospital. METHODS: Patients at the Johns Hopkins Sickle Cell Center for Adults with a readmission in fiscal year 2011 were compared with an age- and sex-matched sample of clinic patients for comorbidities, complications, and prior utilization. Hospitalizations that were followed by readmissions were compared with those that were not as to admitting service, length of stay, and average daily opioid dose. RESULTS: Patients with readmissions had more complications and comorbidities and much higher prior utilization than typical clinic patients, whereas hospitalizations that were followed by readmissions had a longer length of stay but similar opioid doses. CONCLUSIONS: For patients with SCD with a high volume of hospital use, readmissions may be a natural consequence of a high-admission frequency associated with greater disease severity and higher comorbidity.
No takes yet. Share an insight, caveat, or question.
Carroll et al. (2016) conducted a case-control in Sickle cell disease (SCD). Hospital readmission vs. Age- and sex-matched clinic patients without readmission was evaluated on Patient and hospitalization factors including comorbidities, complications, prior utilization, length of stay, and opioid dose. Hospital readmissions in sickle cell disease patients were associated with more complications, higher comorbidities, greater prior utilization, and longer lengths of stay than in typical patients.
Synapse has enriched 10 related papers. Consider them for comparative context: